Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
TC Wehler, M Nonn, B Brandt, CM Britten, M Gröne… - Blood, 2007 - ashpublications.org
In HLA-incompatible hematopoietic stem cell transplantation, alloreactive donor T cells
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
[HTML][HTML] Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
TC Wehler, M Nonn, B Brandt, CM Britten, M Gröne… - Blood, 2007 - Elsevier
In HLA-incompatible hematopoietic stem cell transplantation, alloreactive donor T cells
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
TC Wehler, M Nonn, B Brandt, CM Britten, M Gröne… - Blood, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In HLA-incompatible hematopoietic stem cell
transplantation, alloreactive donor T cells recognizing recipient mismatch HLA cause severe …
transplantation, alloreactive donor T cells recognizing recipient mismatch HLA cause severe …
[PDF][PDF] Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
SA Khan, RG Meyer, C Huber, UF Hartwig, W Herr - BLOOD, 2007 - academia.edu
For many patients with leukemia lacking a matched hematopoietic stem cell donor,
transplantation of HLA-incompatible stem cells remains the only curative treatment option. 1 …
transplantation of HLA-incompatible stem cells remains the only curative treatment option. 1 …
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
TC Wehler, M Nonn, B Brandt, CM Britten, M Gröne… - Blood, 2006 - europepmc.org
In HLA-incompatible hematopoietic stem cell transplantation, alloreactive donor T cells
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
[引用][C] Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
TC WEHLER, M NONN, UF HARTWIG, W HERR… - Blood, 2007 - pascal-francis.inist.fr
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells
from antileukemic and antitumor donor T-cell lines CNRS Inist Pascal-Francis CNRS Pascal …
from antileukemic and antitumor donor T-cell lines CNRS Inist Pascal-Francis CNRS Pascal …
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
TC Wehler, M Nonn, B Brandt, CM Britten… - …, 2007 - pubmed.ncbi.nlm.nih.gov
In HLA-incompatible hematopoietic stem cell transplantation, alloreactive donor T cells
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
recognizing recipient mismatch HLA cause severe graft-versus-host disease (GVHD) …
[引用][C] Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
W TC - Blood, 2007 - cir.nii.ac.jp
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells
from antileukemic and antitumor donor T-cell lines | CiNii Research CiNii 国立情報学研究所 …
from antileukemic and antitumor donor T-cell lines | CiNii Research CiNii 国立情報学研究所 …